Kazuo Tanimoto
Kanazawa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kazuo Tanimoto.
Analytical Biochemistry | 1984
Akio Tomoda; Ken-Ichi Kodaira; Akira Taketo; Kazuo Tanimoto; Yoshimasa Yoneyama
A method is described for the preparation or removal of erythrocyte membranes from hemolysates by a glucose solution. The procedure is simple and rapid, requiring centrifugation at 8000g for 2 min. The preparation has microscopic shape and two-dimensional peptide patterns similar to those of the membrane isolated by conventional procedures (10,000g for 20 min). The present procedure is suitable for dealing with a bulky preparation or for removal of erythrocyte membranes from large volumes of hemolysates to purify enzymes and proteins of soluble or membrane fractions.
Pathology International | 2008
Shogo Katsuda; Yoshikatsu Okada; Yoshio Oda; Kazuo Tanimoto; Satoru Takabatake
An autopsy case of systemic mastocytosis without cutaneous involvement in a 76‐year‐old woman was described. The patient presented with general malaise, chest and epigastric discomfort, flushing of the face and progressive hepatosplenomegaly, and she terminated in hemorrhagic complications of DIC within 2 months. There was neither rash nor urticaria pigmentosa recognizable in the entire course. The diagnosis was made by the histologic identification of abnormal aggregates of mast cells in a bone marrow aspirate. These mast cell granules were chloroacetate esterase‐positive, peroxidase‐negative, and electronmicroscopically they were composed of fine granular materials containing variable numbers of lamellar structures. At autopsy, diffuse infiltration of the mast cells was found in the liver, spleen, bone marrow, lymph nodes, lungs, kidneys, stomach, and adrenal glands.
Vox Sanguinis | 1980
Akio Tomoda; Kiyoh Tanishima; Kazuo Tanimoto; Yoshimasa Yoneyama
On passing ACD blood stored for a year at 4 degrees C through a column of Sephadex G-75, the surviving erythrocytes were separated from hemolyzed cells and plasma. About 18% of stored erythrocytes survived a year of storage, and were spherocytic. The concentration of total ferric hemoglobins in the surviving erythrocytes was about 75% of that in the supernatant. The met-form hemoglobins in the erythrocytes and hemolytic solutions were further analyzed by isoelectric focusing electrophoresis, and (alpha 2+ beta 3+)2 and (alpha 3+ beta 2+)2 valency hybrids were found in addition to methemoglobin. Since the activity of NADH cytochrome b5 reductase was extremely low in the surviving erkythrocytes, the difference in proportion of ferric hemoglobins (valency hjybrids + methemoglobin) in these two fractions might be due simply to the difference in pH between intracellular and extracellular fluids, which is largely reflected in the oxidation rate of hemoglobin. The course of hemoglobin oxidation seems to be through hemoglobins such as (alpha 2+ beta 3+)2 and (alpha 3+ beta 2+)2 to methemoglobin.
Cancer | 1980
Takashi Yoshida; Kenichi Hattori; Shinobu Nakamura; Eiichi Mitamura; Saburo Kobayashi; Shigeki Ohtake; Kazuo Tanimoto
Our simple rapid autoradiography for 3H‐thymidine (3H‐TdR) labeling index (LI) of leukemic cells was introduced. Thirty‐nine adult patients with acute nonlymphocytic leukemia were treated under a new protocol using 3H‐TdR LI as a parameter and inserting a trial of partial synchronization by Ara‐C. The success rate of synchronization by Ara‐C (rise of the LI up to 10%) was 62.5% out of 32 courses. By our regimen the complete remission (CR) rate of 71.4% in 35 first treated cases, that of 44.0% in 25 courses of recurrent cases, and a median survival of 12 months were achieved. A survey of literature revealed that our results were favorably compared with others. Our new protocol is advantageous in permitting one to precisely know the proper time for chemotherapy and thus avoiding unnecessary side effects.
The Journal of the Japanese Society of Clinical Cytology | 1981
Isao Nakanishi; Shogo Katsuda; Masaki Shimamura; Kazuo Tanimoto
自然尿細胞診で腫瘍細胞が検出された腎盂移行上皮癌 (Grade III) を報告し, あわせて最近経験した上部尿路移行上皮癌17症例を校閲し尿細胞診と組織診における腫瘍細胞の異型度や正診に与える因子について検討した. 異型度の高い移行上皮癌においては尿細胞診で比較的容易に腫瘍細胞は検出されたが異型度の低い乳頭状癌においては陽性率は低かった. 細胞診における腫瘍細胞の異型度は比較的よく組織診における細胞異型度を反映しているのが知られた.
Journal of Surgical Oncology | 1991
Yoh Watanabe; Junzo Shimizu; Makoto Oda; Takashi Iwa; Tsutomu Takashima; Ryoichi Kamimura; Masanobu Kitagawa; Akitaka Nonomura; Shinobu Nakamura; Kazuo Tanimoto; Fujitsugu Matsubara; Shigeru Ikegaki; Katuji Yamada
The Journal of the Japanese Society of Clinical Cytology | 2005
Katsuaki Sato; Yoshiko Uwami; Josaku Kawamura; Kazuo Tanimoto; Keiko Okazaki; Yoshimichi Ueda; Shogo Katsuda
Haigan | 1990
Yoh Watanabe; Haruo Kimoto; Takashi Iwa; Tsutomu Takashima; Ryoichi Kamimura; Masanobu Kitagawa; Kazuo Tanimoto; Fujitsugu Matsubara; Shigeru Ikegaki; Katsuji Yamada
The Journal of the Japanese Society of Clinical Cytology | 1990
Yoshikatsu Okada; Isao Nakanishi; Minoru Yoshida; Ryoko Douken; Kazuo Tanimoto
The Journal of the Japanese Society of Clinical Cytology | 2005
Katsuaki Sato; Yoshiko Uwami; Yasuyo Nishida; Kazuo Tanimoto; Yoshimichi Ueda; Shogo Katsuda